These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9132868)

  • 1. [Viral load and monitoring of antiretroviral treatment].
    Soriano V; Mas A; Gómez-Cano M; Villalba N; Bravo R; González-Lahoz J
    Rev Clin Esp; 1996 Dec; 196(12):872-7. PubMed ID: 9132868
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral therapy for human immunodeficiency virus disease: implications for critical care nursing.
    Ress BC
    Crit Care Nurse; 1998 Dec; 18(6):54-62. PubMed ID: 9887722
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiretroviral therapy in HIV/AIDS: update from San Francisco.
    Laurence J
    AIDS Read; 2000 Mar; 10(3):133-4. PubMed ID: 10758008
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapy.
    Navarrete P; Morente V; García F; Alós L; Arnedo M; Plana M; Gil C; Caballero M; Miró JM; Martínez E; Fumero E; Castro P; Blanco JL; Mallolas J; Blanch JL; Cruceta A; Mestre G; Pumarola T; Gallart T; Gatell JM
    Antivir Ther; 2003 Dec; 8(6):635-7. PubMed ID: 14760898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral rounds. Virologic failure: true or false?
    Gallant JE; Shafer R
    AIDS Clin Care; 2005 Sep; 17(9):84-5. PubMed ID: 16201048
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapies. Confronting the limits of success.
    Cohen J
    Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
    [No Abstract]   [Full Text] [Related]  

  • 7. Questions about HIV causing AIDS? Viral load and T-cell (CD4) counts: why they really matter.
    AIDS Treat News; 2001 May; (364):7-8. PubMed ID: 11569964
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of viral load blips, drug boosting, and therapeutic holidays in HIV patient management.
    Bean P
    Am Clin Lab; 2001 Sep; 20(8):11-3. PubMed ID: 11586932
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA community meeting May 16: clinical trials and viral load. Food and Drug Administration.
    AIDS Treat News; 1997 May; (No 270):3. PubMed ID: 11364324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials and viral load: statement for FDA community meeting May 16. Food and Drug Administration.
    James JS
    AIDS Treat News; 1997 May; (No 271):1-4. PubMed ID: 11364367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and response to antiretroviral therapy of non-B subtypes of HIV in antiretroviral-naive individuals in British Columbia.
    Alexander CS; Montessori V; Wynhoven B; Dong W; Chan K; O'Shaughnessy MV; Mo T; Piaseczny M; Montaner JS; Harrigan PR
    Antivir Ther; 2002 Mar; 7(1):31-5. PubMed ID: 12008785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiviral therapy: when to begin, which goals should be set, what must be kept in mind? Tips for nonspecialists].
    Jablonowski H
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():10-1. PubMed ID: 16385862
    [No Abstract]   [Full Text] [Related]  

  • 14. AIDS researchers seek criteria for vaccines.
    Check E
    Nature; 2003 May; 423(6936):107. PubMed ID: 12736647
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-HIV-1 intermittent drug intensification in HIV-1-infected patients naive for antiretrovirals.
    Rusconi S; Argenteri B; Galli M; d'Arminio-Monforte A; Moroni M
    Antivir Ther; 1999; 4(3):183-4. PubMed ID: 12731759
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular bases in the search for drugs for treating AIDS. Achievements and possible prospects].
    Kraevskiĭ AA
    Mol Biol (Mosk); 1999; 33(3):343-52. PubMed ID: 10519109
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognosis depends on viral load. AIDS: frequently too much time is wasted].
    Fortschr Med; 1997 Jun; 115(16):14. PubMed ID: 9280745
    [No Abstract]   [Full Text] [Related]  

  • 18. Rationale for early antiretroviral therapy in patients with CD4 cell counts > 500 cells/mm3.
    Soriano V; Gómez-Cano M; Mas A; Villalba N; Bravo R; González-Lahoz J
    Antivir Ther; 1996 Dec; 1(4):264-5. PubMed ID: 11324829
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination therapy dramatically reduces viral load.
    AIDS Patient Care STDS; 1996 Apr; 10(2):131. PubMed ID: 11361695
    [No Abstract]   [Full Text] [Related]  

  • 20. [Established and new drugs. Antiretroviral therapy 2002].
    Jablonowski H
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():58-61. PubMed ID: 12043077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.